Carbone C, Piro G, Tamburrino A, Mina MM, Zanini S, Tortora G, Melisi D. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP [Internet]. 15Sep.2013 [cited 5May2024];14(5S):562. Available from: http://www.serena.unina.it/index.php/jop/article/view/1866